NDT Advance Access published online on April 27, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl211
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine III, Division of Nephrology and Dialysis, University Hospital Vienna, Austria
* To whom correspondence should be addressed. Background. Neither the prevalence nor the associated risk factors of late post-transplant renal tubular acidosis (RTA) are known. Methods. We conducted a cross-sectional study with 576 patients for more than 12 months after kidney transplantation, and a glomerular filtration rate (GFR) >40 ml/min. RTA was diagnosed by measurement of the urine anionic gap, urine pH and plasma potassium during acidosis, and fractional bicarbonate excretion after bicarbonate loading. Uni- and multi-variable analysis were used to isolate factors associated with post-transplant RTA, and with the different RTA subtypes. Results. All patients (n = 76) had distal post-transplant RTA. A significant association with the presence of RTA was found for the intake of tacrolimus or renin-angiotensin-aldosterone blockers, the Parathyroid hormone level and the GFR. Type Ia (classic, distal), type Ib (hyperkalaemic, voltage-dependent), rate-limited and type IV RTA were present in 37, 14, 21 and 28% of the patients. Acute transplant rejection was the only significant different parameter between the RTA subtypes and more often present in patients with type Ia or Ib RTA. Conclusions. We conclude that a significant fraction of stable long-term renal transplant recipients with adequate graft function develop post-transplant RTA, with a preponderance for type Ia and type IV, and absence of type II. In addition, acute transplant rejection seems to have an influence on the subtype of RTA present post-transplantation.
Received January 23, 2006
Accepted March 24, 2006
Original Article
Complete renal tubular acidosis late after kidney transplantation
Christoph Schwarz 1,
Thomas Benesch 2,
Katharina Kodras 1,
Rainer Oberbauer 1,
and
Martin Haas 1 *
2 Department of Medical Statistics, University Hospital Vienna, Austria
Martin Haas, E-mail: martin.haas{at}meduniwien.ac.at
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Mohebbi, M. Mihailova, and C. A. Wagner The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins Am J Physiol Renal Physiol, August 1, 2009; 297(2): F499 - F509. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mitterbauer, G. Heinze, A. Kainz, R. Kramar, W. H. Horl, and R. Oberbauer ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1742 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Sharma, R. K. Sharma, R. Kapoor, A. Kornecki, S. Sural, and G. Filler Incomplete distal renal tubular acidosis affects growth in children Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2879 - 2885. [Abstract] [Full Text] [PDF] |
||||

